Differences in safety and efficacy of oral anticoagulants in patients with non‐valvular atrial fibrillation: A Bayesian analysis
Z Sun, Y Liu, Y Zhang, X Guo… - International Journal of …, 2019 - Wiley Online Library
Background Novel oral anticoagulants are the cornerstone of therapy for non‐valvular atrial
fibrillation patients to lower the risk of ischaemic stroke. Given the lack of head‐to‐head …
fibrillation patients to lower the risk of ischaemic stroke. Given the lack of head‐to‐head …
Differences in safety and efficacy of oral anticoagulants in patients with non-valvular atrial fibrillation: A Bayesian analysis.
Z Sun, Y Liu, Y Zhang, X Guo, Y Xu - International Journal of Clinical …, 2019 - europepmc.org
Background Novel oral anticoagulants are the cornerstone of therapy for non-valvular atrial
fibrillation patients to lower the risk of ischaemic stroke. Given the lack of head-to-head …
fibrillation patients to lower the risk of ischaemic stroke. Given the lack of head-to-head …
Differences in safety and efficacy of oral anticoagulants in patients with non-valvular atrial fibrillation: A Bayesian analysis
Z Sun, Y Liu, Y Zhang, X Guo… - International journal of …, 2019 - pubmed.ncbi.nlm.nih.gov
Background Novel oral anticoagulants are the cornerstone of therapy for non-valvular atrial
fibrillation patients to lower the risk of ischaemic stroke. Given the lack of head-to-head …
fibrillation patients to lower the risk of ischaemic stroke. Given the lack of head-to-head …